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Abstract 
Members of the Tre2/Bub2/Cdc16 (TBC), lysin motif (LysM), domain catalytic (TLDc) protein family are associated with 
multiple neurodevelopmental disorders, although their exact roles in disease remain unclear. For example, nuclear receptor 
coactivator 7 (NCOA7) has been associated with autism, although almost nothing is known regarding the mode-of-action 
of this TLDc protein in the nervous system. Here we investigated the molecular function of NCOA7 in neurons and gener-
ated a novel mouse model to determine the consequences of deleting this locus in vivo. We show that NCOA7 interacts with 
the cytoplasmic domain of the vacuolar (V)-ATPase in the brain and demonstrate that this protein is required for normal 
assembly and activity of this critical proton pump. Neurons lacking Ncoa7 exhibit altered development alongside defective 
lysosomal formation and function; accordingly, Ncoa7 deletion animals exhibited abnormal neuronal patterning defects and 
a reduced expression of lysosomal markers. Furthermore, behavioural assessment revealed anxiety and social defects in mice 
lacking Ncoa7. In summary, we demonstrate that NCOA7 is an important V-ATPase regulatory protein in the brain, modu-
lating lysosomal function, neuronal connectivity and behaviour; thus our study reveals a molecular mechanism controlling 
endolysosomal homeostasis that is essential for neurodevelopment.
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Abbreviations
ASD  Autism spectrum disorder
AT1A1  Sodium/potassium-transporting ATPase 
subunit alpha-1
CB  Calbindin
CNS  Central nervous system
ERAP40  Estrogen receptor (ER)-associated protein 
140
GABA  Gamma-aminobutyric acid
GRAM  Rab-like GTPase activators and 
myotubularins
IFN  Interferon
NCOA7  Nuclear receptor coactivator 7
NCOR1  Nuclear receptor corepressor 1
NDD  Neurodevelopmental disorders
OXR1  Oxidation resistance 1
PIP  Phosphoinositide
SRC1  Steroid receptor coactivator 1
TLDc  Tre2/Bub2/Cdc16 (TBC), lysin motif (LysM), 
domain catalytic
TBC1D24  Tre2/Bub2/Cdc16 (TBC)1 domain family 
member 24
VGAT  Vesicular GABA transporter
VGLUT  Vesicular glutamate transporter
Introduction
The susceptibility to neurodevelopmental disorders (NDD) 
including autism spectrum disorder (ASD) is driven typi-
cally by multiple genetic components, and studies of rare 
cases have uncovered the importance of new mutations 
in the search for common molecular pathways and novel 
clinical interventions [1, 2]. Many of the candidate genes 
associated with NDD are clustered around known aspects 
of dendritic development and synapse formation [3, 4]; 
however, there is an increasing appreciation that funda-
mental, ubiquitous mechanisms of cellular maintenance are 
likely to play a key role. For example, neurons are highly 
dependent on autophagy and the endolysosomal system 
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for their normal function and there are  cases where the 
manipulation of such pathways can either be beneficial 
[5] or detrimental [6] to neurodevelopment and behaviour 
in mammalian systems. Specifically, neurons rely on effi-
cient lysosomal degradative activity due to their postmi-
totic nature, cellular polarisation and structural complex-
ity [7, 8]. Defective vesicular acidification, including the 
intraluminal pH of lysosomes, will ultimately influence 
the activity of degradative enzymes [9] and as such will 
be detrimental to the membrane and protein recycling 
events required for neuronal migration, dendritic elonga-
tion and neuronal connectivity, all aspects implicated in 
NDD [10–12].
One family of proteins increasingly associated with 
NDD share the highly-conserved Tre2/Bub2/Cdc16 
(TBC), lysin motif (LysM), domain catalytic (TLDc) 
domain, initially implicated in the oxidative stress 
response [13, 14]. Since the advent of exome sequenc-
ing studies, causative mutations have been described in 
the TLDc proteins Tre2/Bub2/Cdc16 (TBC)1 domain 
family member 24 (TBC1D24) and oxidation resistance 
1 (OXR1) in a range of NDD, some characterised by sei-
zures and neurodegeneration as well as developmental 
delay [15–17]. Although both proteins have been proven 
to regulate aspects of neurotransmission, neurodevelop-
ment and cellular survival in a number of model systems, 
their exact molecular function in disease remains unclear 
[13, 18–22]. A third member of the TLDc family highly-
expressed in the central nervous system (CNS) is nuclear 
receptor coactivator 7 (NCOA7), and the most closely 
related to OXR1 [23]. NCOA7 was initially identified as 
estrogen receptor (ER)-associated protein 140 (ERAP140) 
and contains a putative ER binding domain [24, 25]; 
however, the role of this TLDc protein in genome-wide 
transcriptional regulation has not been demonstrated and 
almost nothing is known regarding the molecular function 
of the gene in the nervous system.
Interestingly, a large-scale ASD network study utiliz-
ing the BrainSpan human transcriptome database identi-
fied NCOA7 as a ‘hub’ gene displaying one of the strongest 
interaction network correlations with disease [26]. Then, 
more recently, systematic analysis of exome data from the 
Autism Sequencing Consortium identified a recessive case 
of ASD caused by a homozygous nonsense mutation in 
NCOA7 [27]. Thus, given the known associations of other 
TLDc genes with NDD and the lack of functional knowl-
edge regarding NCOA7, here we generated a new mouse 
model to investigate the significance of Ncoa7 loss-of-
function for neurodevelopment and behaviour, and uncover 
the vital role of NCOA7 in endolysosomal homeostasis in 
neurons.
Results
Generation of a novel, viable Ncoa7 deletion mouse 
model
To first establish the distribution of Ncoa7 in the develop-
ing central nervous system, we carried out in situ hybridi-
sation at a range of timepoints in wild-type (WT) mice. 
These data show that Ncoa7 is widely expressed in all 
major regions of the brain, from embryonic and neona-
tal stages and into adulthood (Supplementary Figure 
S1). NCOA7 is also expressed as a number of isoforms 
in mammalian tissues; several full-length containing all 
of the annotated domains (NCOA7), but also a much 
shorter isoform with a unique first exon followed by the 
TLDc domain alone (NCOA7-B; Supplementary Figure 
S2A) [13, 23, 28, 29]. Our previous work in the mouse 
has demonstrated that loss of all isoforms of the closely-
related TLDc gene Oxr1 is required to generate an overt 
neurological phenotype in vivo [30]. Therefore, to deter-
mine whether a similar phenomenon occurs for Ncoa7, 
and to investigate molecular mechanisms in the context of 
Ncoa7 total loss-of-function, we generated a novel mouse 
knockout model in which the entire coding region was 
deleted by CRISPR-Cas9 (Supplementary Figure S2A). 
Mice homozygous for the approximate 157 kb deletion 
(Ncoa7del/del or DEL, Supplementary Figure S2A-B) were 
viable and RT-PCR, in situ hybridisation and Western 
blotting confirmed that all Ncoa7 isoforms are absent in 
DEL tissue (Supplementary Figure S2C–E). The gross 
brain structure was comparable between littermate WT and 
DEL animals, with no differences observed from quantita-
tive morphometric analysis in adult mice (Supplementary 
Figure S2F–N). In addition, there was no indication of 
overt cell death in DEL brains as tested by caspase-3 stain-
ing up to 18 months of age (Supplementary Figure S2O).
NCOA7 interacts with the V‑ATPase in vivo 
and modulates complex assembly
The vacuolar (V)-ATPase is a multi-subunit ATP-depend-
ent proton pump, comprising of cytosolic (V1) and inte-
gral membrane (V0) domains, that is vital for maintaining 
the acidic intraluminal pH of multiple cellular organelles 
[31]. In a screen for protein interactors of this complex 
in the kidney, NCOA7 was identified as a potential bind-
ing partner [32, 33]. In the nervous system, the V-ATPase 
plays a vital role in neuronal and synaptic physiology, with 
mutations in specific subunits causing neurodevelopmental 
disease [34, 35]. Therefore, in view of the recent asso-
ciation of NCOA7 loss-of-function mutations in autism 
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[27], and the distinct lack of knowledge regarding NCOA7 
function in the nervous system, we investigated neuronal 
V-ATPase function in vivo using our new Ncoa7 deletion 
model.
First, we assessed the endogenous protein–protein 
interactions of NCOA7 with individual subunits of the 
V-ATPase in  vivo. Co-immunoprecipitation experi-
ments from sub-fractionated WT brain tissue using an 
anti-NCOA7 antibody demonstrated an interaction of 
the protein with the cytosolic V1 subunits ATP6V1B2, 
ATP6V1A(1) and ATP6V1C, with DEL mice samples 
used to confirm the specificity of the binding (Fig. 1a). 
In addition, we confirmed the NCOA7:ATP6V1B2 inter-
action by reciprocal co-immunoprecipitation with an 
anti-ATP6V1B2 antibody in both the cytoplasmic and 
membrane fractions (Fig. 1b). Interestingly, however, an 
interaction with the integral membranous V0 subunits 
ATP6V0a1 and ATP6v0d1 could not be detected (Fig. 1a). 
Before investigating the functional consequences of this 
interaction in the context of Ncoa7 disruption, we next 
Fig. 1  NCOA7 interacts specifi-
cally with V1 domain subunits 
of the V-ATPase. a Western 
blotting for V-ATPase V1 and 
V0 subunits after immuno-
precipition (IP) of membrane, 
cytosolic and nuclear fractions 
from WT and DEL adult mouse 
whole brain using anti-NCOA7. 
Blots of equally loaded protein 
extracts prior to IP (input) 
are also shown. The markers 
AT1A1, tubulin and Histone 
H3 are used as loading controls 
for the membrane, cytosolic 
and nuclear fractions, respec-
tively. b Western blot detection 
of NCOA7 after IP from the 
same adult mouse whole brain 
fractions using anti-ATP6V1B2. 
c Immunofluorescence for HA-
tagged NCOA7 and myc-tagged 
ATP6V1B2 expressed in pri-
mary neurons (7–10 DIV) with 
co-localisation demonstrated by 
the merged signal. Scale bar: 
20 µm. d PIP membrane show-
ing the immunoreactive spots 
relative to positive NCOA7-PIP 
binding: 1 Lysophosphatidic 
acid; 2 Lysophosphatidylcho-
line; 3 Phospatidylinositol 
(PtdIns); 4 PtdIns(3)P; 5 
PtdIns(4)P; 6 PtdIns(5)P; 7 
Phosphatidylethanolamine; 
8 Phosphatidylcholine; 9 
Sphingosine 1-phosphate; 10 
PtdIns(3,4)P2; 11 PtdIns(3,5)
P2; 12 PtdIns(4,5)P2; 13 
PtdIns(3,4,5)P3; 14 Phospha-
tidic acid; 15 Phosphatidylser-
ine; B Blank
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measured the expression levels of a range of V1 and V0 
V-ATPase subunits in whole brain tissue from DEL mice, 
and no significant differences were found at the protein 
level (Supplementary Figure S3A–F).
NCOA7 has been described as being nuclear-localised 
[23, 24], yet the Rab-like GTPase activators and myo-
tubularins (GRAM) domain, present in the N-terminal 
region, is found in a number of membrane-associated 
proteins [36]. Therefore, to further support the inter-
action of NCOA7 with a membrane-associated protein 
complex, and in view of the lack of reliable antibodies 
for immunocytochemistry, we co-expressed NCOA7 and 
ATP6V1B2 in primary neurons. Immunostaining showed 
a positive signal for NCOA7 in the cytoplasm and at the 
membrane in both WT and DEL cells that co-localised 
with the ATP6V1B2 subunit (Fig. 1c). Indeed, our data 
showing a lack of detectable endogenous NCOA7 in the 
nuclear fraction of brain tissue, but robust expression 
in the cytoplasmic and membrane fractions, supports 
these data (Fig. 1a). In addition, we investigated whether 
NCOA7 is able to interact with membrane-associated 
phosphoinositides (PIPs), given their known importance 
for V-ATPase functionality and known physical proxim-
ity to the complex [37–39]. Using a protein-lipid overlay 
assay, we discovered that recombinant NCOA7 can bind 
specifically to a range of PIPs (Fig. 1d); importantly, 
those found to interact are known to be required for cor-
rect localisation and activity of the V-ATPase [37–39].
The correct assembly of the V-ATPase is essential for 
normal function of the complex, thus the reversible asso-
ciation and dissociation of the V1 and V0 subunits is an 
important regulatory feature [39, 40]. Given the appar-
ent specificity of NCOA7 for the cytoplasmic subunits 
of the V-ATPase, we decided to study whether loss of 
Ncoa7 would affect the assembly of the V1 domain on 
the membranous V0 domain. Subcellular fractionation 
experiments from WT and DEL primary cortical neurons 
did not reveal any differences in the protein levels of the 
V-ATPase subunits in the cytosolic fraction, consistent 
with our data from brain tissue (Fig. 2a, b, d, f). Interest-
ingly, we found a significant reduction in the amount of 
the V1 subunits ATP6V1B2 and ATP6V1A1 present in 
the membrane fraction of DEL neurons compared to WT 
(Fig. 2c, e), although no such reduction was found for 
ATP6V1D (Fig. 2g). Furthermore, the level of the V0 
subunit ATP6V0d1 was also unaltered between genotypes 
in the membrane fraction (Fig. 2h). Together, these find-
ings reveal that NCOA7 is an interactor of the V1 domain 
of the V-ATPase in the brain, such that, in the absence 
of all Ncoa7 isoforms, the ATP6V1B2 and ATP6V1A1 
subunits may not be correctly stabilised at membrane 
sites where fully functional V-ATPases are maintained.
Ncoa7 deletion results in lysosomal dysfunction 
in neurons
Lysosomal V-ATPases are critical for regulating the opti-
mal interluminal pH for enzymes, such as cathepsins and 
hydrolases, to facilitate the degradation of macromolecules 
derived from endocytic and autophagic pathways [41]. Thus 
to determine whether the loss of the NCOA7 interaction with 
the V-ATPase is critical for normal lysosomal function in 
neurons, we labelled the endolysosomal pathway using the 
pH-sensitive LysoTracker dye [41]. Live labelling in pri-
mary cortical cells revealed a reduction in the number of 
LysoTracker positive organelles in DEL cells compared to 
WT, accompanied by a significant decrease of their fluo-
rescence signal (Fig. 3a–c). These data are suggestive of a 
change in lysosomal function; but to more accurately quan-
tify the acidity of endocytic compartments, we loaded pri-
mary cells with pH-responsive FITC-dextran followed by 
live cell imaging, revealing a significant increase in pH of 
over 0.5 units in DEL neurons compared to WT controls 
(Fig. 3d–f).
We next analysed LAMP1-positive organelles as a quan-
tifiable marker of lysosomes by immunocytochemistry. A 
significant reduction in the number of LAMP1-positive 
puncta was detected in DEL primary neurons versus WT 
cells, in parallel with significantly lower LAMP1 fluores-
cence intensity in mutant cells (Fig. 3g–i). Crucially, over-
expressing NCOA7 in DEL neurons was sufficient to rescue 
both phenotypes to WT values (Fig. 3h, i). Next, to further 
quantify lysosomal function in DEL cells, we utilised two 
independent assays in which the degradation of ectopically 
introduced compounds was measured [42, 43]. These data 
showed a significant reduction in the processing of both 
exogenous DQ-BSA and Dextran-AF594 in DEL primary 
cortical cells compared to WT, revealing reduced lysosomal 
degradative capacity in mutant neurons (Fig. 4a–d). Lyso-
somal defects are known to lead to cytosolic accumulation 
of undegraded material in post-mitotic neuronal cells [44, 
45]. For this reason, we investigated whether the lysosomal 
alterations found in NCOA7 DEL mutant cells may lead 
to cytosolic accumulations in the neuronal soma. Conven-
tional transmission electron microscopy on cell bodies of 
primary cortical neurons confirmed a signficant increase in 
the presence of cytosolic granules in DEL neurons versus 
WT, suggesting an accumulation of non-degraded material 
is due to the loss of Ncoa7 (Fig. 5a–c). Taken together, these 
findings reveal that NCOA7 is required for normal lysosomal 
function in neurons.
Lysosomal function is intimately linked to autophagy, 
as lysosomes are targeted by autophagosomes to degrade 
engulfed materials. We, therefore, investigated the 
autophagy process by labelling LC3b and p62 in cultured 
primary cortical neurons. Neurons derived from DEL mice 
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displayed a small but significant increase in the number of 
LC3b-positive organelles versus WT cells (Supplementary 
Figure S4A–C), while the number p62-positive were unaf-
fected (Supplementary Figure S4D, E). Increased LC3b can 
be indicative of increased autophagosome formation or a 
decreased autophagic turnover, resulting in a build-up of 
LC3b-labelled autophagosomes. Given these observations 
in primary neurons, we questioned next whether the absence 
of Ncoa7 may cause detectable lysosomal alterations in vivo. 
We examined the protein levels of endolysosomal markers 
from WT and DEL whole brain extracts. The endosomal 
marker Rab7, together with the lysosomal marker LAMP1 
and the lysosomal enzymes cathepsin B and cathepsin D, 
were significantly decreased as observed by Western blot 
analysis (Supplementary Figure S5A–F). These data are 
further supported by an even more pronounced reduction 
in LAMP1 protein expression in the membrane fraction of 
primary neurons from DEL mice compared to WT con-
trols (Fig. 2a, i). Overall, our findings reveal that loss of 
Ncoa7 affects several aspects of endolysosomal physiology 
and homeostasis in neuronal cells, consistent with aberrant 
V-ATPase function or formation.
V‑ATPase‑associated defects in the kidney 
from mice lacking Ncoa7
As stated above, an association between the V-ATPase and 
NCOA7 had been postulated from a protein interaction 
Fig. 2  NCOA7 modulates 
V-ATPase V1/V0 complex 
assembly. a Primary cortical 
cell homogenates from WT 
and DEL mice were separated 
into cytosolic (CYTO) and 
membrane (MEM) fraction by 
sedimentation and subjected 
to Western blotting using 
antibodies against the V1 or 
V0 subunits as shown. The 
markers vinculin and AT1A1 
are used as loading controls 
for the cytosolic and mem-
brane fractions, respectively. 
b Quantification of cytosolic 
ATP6V1B2 versus vinculin and 
c membrane ATP6V1B2 versus 
AT1A1 from both genotypes. d 
Total quantification of cytosolic 
ATP6V1A1 versus vinculin and 
e membrane ATP6V1A1 versus 
AT1A1 from both genotypes. f 
Total quantification of cytosolic 
ATP6V1D1 versus vinculin 
and g membrane ATP6V1A1 
versus AT1A1 from both 
genotypes. h, i Total quantifica-
tion of ATP6V0d1 and LAMP1 
versus the membrane loading 
control AT1A1. j, k Expres-
sion ratios of ATP6VA1 and 
ATP6V1D1 versus ATP6V1B2. 
Data are expressed as the 
the mean ± SEM from n = 4 
independent cell preparations. 
*p < 0.05, **p < 0.01; unpaired 
Student’s t test
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screen in the mouse kidney [32]. Thus we wanted to deter-
mine whether our data confirming NCOA7 binding and the 
influence on V-ATPase-associated function could be reca-
pitulated in the kidney using our new DEL model. We began 
by showing that the kidney-specific ATP6V1B1 V1 subunit 
could successfully and specifically bind to NCOA7 in vivo 
by co-immunoprecipitation (Supplementary Figure S6A, 
B). Next, we assessed the expression of ATP6V1B1 in the 
kidney; interestingly, unlike V1 subunits in the brain, we 
were able to detect a significant reduction of protein lev-
els in DEL tissue compared to WT (Supplementary Figure 
S6C). Importantly, the acidification of urine via the interca-
lated cells of the kidney relies on the correct functionality 
of the V-ATPase [46]. Therefore, we went-on to compare 
urine pH levels in WT and DEL mice. These data revealed 
a significant increase in urine pH from a large cohort of 
Fig. 3  Ncoa7 deletion increases lysosomal pH and reduces lysosomal 
density in cortical neurons. a Representative images of LysoTracker 
Red live-labeled acidic organelles in WT and DEL primary cortical 
neurons (10–12 DIV) with DAPI. Scale bar: 20  µm. b LysoTracker 
fluorescence intensity and c LysoTracker-positive organelles quanti-
fication from WT and DEL primary cortical neurons. d Representa-
tive images of FITC-dextan live-labelled primary cortical neurons 
(7–10 DIV) from WT and DEL mice. Scale bar: 20 µm. e Calibration 
curve using pH standards used to calculate acidity of FITC-dextran 
live-labelled organelles (total n = 167). f pH quantification of WT 
(total n = 122) and DEL (total n = 140) live-labelled oranelles using 
the standard curve. g Representative images of LAMP1 staining (red, 
left panels), plasma membrane staining (middle panels) and their 
merged signals (right panels) in WT, DEL, and the RESCUE experi-
ment from DEL neurons expressing exogenous NCOA7-GFP (lower 
panels). Scale bar: 20 µm. h LAMP1 fluorescence intensity and i the 
number of LAMP1-positive organelles was also quantified. Data are 
expressed as the mean ± SEM. Data points represent individual cells 
and n = 3 independent primary cell preparations were used for all 
panels. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; unpaired 
Student’s t test (b, c, f) and one-way ANOVA/Bonferroni’s multiple 
comparison test (h, i)
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DEL animals (Supplementary Figure S6D); these findings 
are not only consistent with aberrant V-ATPase function in 
the kidney, but are also in agreement with the directionality 
of our lysosomal acidity measurements in primary neurons 
(Fig. 3F).
Loss of Ncoa7 impacts neuronal development 
and synaptic contacts in vivo
Lysosomal degradative processes are essential for neuronal 
function and play key roles in nerve cell development and 
connectivity [47]. Therefore, as the role of NCOA7 in neu-
rodevelopment has not been studied previously, we began 
by examining neurite extension and arborisation in DEL 
primary cortical cells. While the total length of the neu-
ronal process were unaltered between genotypes (Fig. 6a–c), 
we found a significant increase in the number of proximal 
neurites in DEL neurons compared to WT, a phenotype that 
we were able to rescue by expressing exogenous NCOA7 
(Fig. 6d). Later in their developmental stages, neurons estab-
lish functional networks balancing excitatory and inhibitory 
inputs. By measuring the juxtaposition of the presynaptic 
and postsynaptic inhibitory markers (VGAT and Gephyrin, 
respectively), we also uncovered a reduction of inhibitory 
contacts in DEL neurons when compared to WT (Fig. 6e, 
f). Importantly, this reduction could be rescued by the addi-
tion of exogenous NCOA7 (Fig. 6e, f); these data, therefore, 
revealing a fundamental role for NCOA7 in synaptic con-
nectivity. On the contrary, when we analysed excitatory syn-
apses by labelling with VGLUT1 and Homer1 on WT and 
DEL neurons, no statistical differences were found (Fig. 6g, 
h).
Next, we went on to analyse similar synaptic connections 
in WT and DEL mice in vivo using brain tissue by quan-
titative immunofluorescence of excitatory (VGLUT1) and 
inhibitory VGAT-positive synapses. While no differences 
in VGLUT1-positive puncta were found in the somatosen-
sory cortex between WT and DEL mice (Fig. 7a, b), we 
found a significant decrease of VGAT-positive puncta in the 
same region in mutant animals (Fig. 7a, c). To complement 
these findings, we also assessed GABAergic interneurons, 
focussing on the calbindin (CB)-positive subtype that target 
Fig. 4  Ncoa7 deletion reduces lysosome degradative activity. a Rep-
resentative WT and DEL primary cortical neurons (10–12 DIV) and 
the relative RESCUE experiment (DEL neurons expressing exog-
enous full-length NCOA7) loaded with the fluorogenic substrate for 
lysosomal proteases DQ-Red-BSA and live-imaged at the time points 
indicated. Scale bar: 20 µm. b DQ-BSA de-quenching was quantified 
at different time points to analyse hydrolisation. c Representative WT, 
DEL and RESCUE neurons loaded with Dextran-AlexaFluor 594 and 
live-imaged at the time points indicated. Scale bar: 20 µm. d Dextran 
degradation was quantified by analysing quenching as a result of lys-
osomal degradative activity. Data are expressed as the mean ± SEM 
from n = 3 independent primary cell preparations. **p < 0.01, 
***p < 0.001; one-way ANOVA/Bonferroni’s multiple comparison 
test
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dendritic compartments of other GABAergic neurons and 
pyramidal cells [48, 49, 50, 51]. Interestingly, the number 
of CB-positive interneurons was significantly reduced in the 
DEL somatosensory and visual cortex (Fig. 7d–f). Overall, 
these neuropathological results reveal an as-yet unreported 
role for NCOA7 in neuronal development, synaptogenesis 
and formation of cortical inhibitory circuits in vivo.
Ncoa7 deletion causes anxiety and social 
impairments in mice
Constitutive homozygous mouse knockout models of the 
TLDc genes Oxr1 and Tbc1d24 result in severe phenotypes 
that preclude the analysis of total loss-of-function in the 
context of adult behaviour [30, 51]. The viability of our 
new DEL model thus allowed us to investigate whether the 
absence of Ncoa7 would cause behavioural alterations rel-
evant to the gene’s known links to autism [27], or other fea-
tures observed in TLDc gene rodent models, such as ataxia 
[30]. Moreover, lysosomal dysfunction is implicated in a 
range of neurobehavioual disorders, including those classi-
fied by anxiety and intellectual disability [5–10]. Therefore, 
we performed a battery of behavioural tests on adult WT 
and DEL mice.
As an initial assessment of anxiety-related behaviour we 
used the light/dark box test. These data revealed a prefer-
ence for DEL mice to remain in the dark and to make fewer 
visits between the light and the dark arenas compared to 
WT controls (Fig. 8a, b). These findings were consistent 
with additional data from the elevated zero-maze, where 
DEL mice spent more time in the closed area and entered 
the open area less frequently compared to WT littermates 
(Fig. 8c, d). Given that the interpretation of such tests can 
be confounded by motor impairment, we decided to analyse 
spontaneous activity and motor co-ordination using the open 
field and rotarod tests, respectively. The open field did not 
reveal any differences in mean velocity or total distance trav-
elled between WT and DEL mice (Supplementary Figure 
S5A-B) and both genotypes performed equally well on the 
rotarod (Supplementary Figure S7C). These data indicate 
that loss of Ncoa7 results in anxiolytic behaviour in mice 
without affecting motor capacity. Next, we examined aspects 
of cognition and memory by studying spatial novelty pref-
erence in a Y-maze and cued/contextual fear conditioning. 
Mice of both genotypes showed similar exploratory patterns 
during the habituation period and, above-chance preference 
for the novel arm in the Y-maze (Supplementary Figure 
S7D–G). During fear conditioning, while a decrease of the 
freezing episodes was observed during the training in DEL 
mice when compared to WT (Supplementary Figure S7H), 
no differences were observed in the freezing time during 
the training (Supplementary Figure S7I) or in any of the 
parameters analysed during both cue and context fear con-
ditioning between the two genotypes (Supplementary Figure 
S7J–M). These data suggest that DEL mice are not signifi-
cantly impaired in short-term memory acquisition and recall.
We also used the three-chamber test to analyse social-
related behaviours in DEL mice. As observed in both the 
Fig. 5  Ultrastructural analysis of undegraded material in WT and 
NCOA7-DEL primary cortical neurons. a Representative micro-
graphs obtained from WT (left panel) and DEL (right panel) pri-
mary neurons. b Orange arrows highlight the granule-like struc-
tures that accumulate in the neuronal soma in DEL neurons. Scale 
bar: 1000  nm. c, d Quantification of the density (c) and percentage 
of accumulation-positive micrographs (d). Data are expressed as the 
mean ± SEM; n = 75 and n = 83 micrographs for WT and DEL neu-
rons, respectively, from n = 3 independent preparations. *p < 0.05; 
one-way ANOVA/Bonferroni’s multiple comparison test
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open field and Y-maze, no differences in the overall dis-
tance travelled were observed between genotypes during 
the task (Supplementary Figure S7N). Interestingly, we 
found that DEL mice spent less time with the novel mouse 
in the social novelty aspect of the test compared to the 
control WT littermates (Fig. 8e), although there were no 
differences frequency of visits between chambers (Fig. 8f). 
Furthermore, no differences were found in the time spent 
with the novel object, nor the frequency of visit to the novel 
object between the two genotype (Fig. 8g–h), suggesting 
that the previous observation was specific to interactions 
with another mouse. To test that this social impairment 
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was not a result of submissive behaviour in DEL mice, we 
carried out the tube social dominance test, and these data 
suggested the level of submission/dominance was identical 
between the two genotypes (Supplementary Figure S7O). 
These results indicate that Ncoa7 deletion results in impaired 
social behaviours in mice.
One functional allele of either Ncoa7 or Oxr1 
is required for viability in mice
The lack of an overt neurodegenerative phenotype in DEL 
mice was somewhat surprising considering the data from 
other TLDc rodent knockout models [30, 52]. We reasoned 
that this might reflect functional compensation by other 
TLDc proteins in the brain in response to a lack of NCOA7, 
and in particular OXR1 as the closest family member with 
the identical composition of protein domains [23]. How-
ever, Western blots from adult brain showed no differences 
in either OXR1 or TBC1D24 at the protein level between 
DEL and WT mice (Fig. 9a). Next, we carried out further 
expression analysis for Oxr1 and Ncoa7 in the brain to deter-
mine, where there may be detectable regions of co-expres-
sion. Indeed, there are many regions of the brain, where 
cells express both genes at a high level, including the motor 
cortex and hippocampus (Supplementary Figure S1). In 
the cerebellum, however, a generally reciprocal expression 
pattern is observed with Oxr1 expressed predominantly in 
the granule cell layer, whereas Ncoa7 is highly enriched in 
Purkinje cells (Fig. 9b and Supplementary Figure S1). From 
these data, despite no evidence for an induction of expres-
sion, we hypothesise that Oxr1 may be able to compensate 
for a total lack of all Ncoa7 isoforms in our DEL model.
To investigate further the requirement for Oxr1 and Ncoa7 
in vivo, we decided to cross the NCOA7 DEL mutants to our 
previously described constitutive Oxr1 knockout model in 
which all isoforms of the gene are disrupted (Oxr1d/d) [53]. 
We discovered that mice carrying only one functional allele 
of either Ncoa7 or Oxr1 were viable and were born at the 
expected Mendelian ratios (Supplementary Table S1). In 
addition, while Oxr1d/+/Ncoa7del/del mice did not show any 
signs of cell death in the brain up to 18 months of age (data 
not shown), Oxr1d/d/Ncoa7 heterozygous DEL knockout 
(Ncoa7del/+) mutants showed the same phenotypic pattern 
of early-onset ataxia as Oxr1d/d animals. Thus, to ascertain 
whether the distinctive neuropathology of Oxr1d/d mice was 
modified by the loss of one Ncoa7 allele, we quantified cell 
death in cerebellar sections at postnatal day (P)22; these 
data indicated that there was no significant difference in the 
severity of neurodegeneration between Oxr1d/d/Ncoa7del/+ 
and Oxr1d/d/Ncoa7+/+ mice (Supplementary Figure S8).
Interestingly, from all the breeding carried out, no live 
double knockouts (Oxr1d/d/Ncoa7del/del) were born (Supple-
mentary Table S1), suggesting that mice of this genotype 
are not viable. We also carried out genotyping of E8.5–9.5 
embryos from the same genetic cross and again no double 
homozygous knockout genotypes were obtained (Supple-
mentary Table S1). Together, these data show for the first 
time the essential requirement for at least one functional 
allele of Ncoa7 or Oxr1 for embryonic development and 
post-natal viability and emphasises the functional impor-
tance of these two TLDc proteins in vivo.
Discussion
Here we demonstrate for the first time in vivo that NCOA7 
binds to the cytoplasmic V1 domain of the V-ATPase and 
that it also modulates the assembly and functionality of 
this essential proton pump in the brain. Importantly, we 
could also rescue the defects in lysosomal homeostasis we 
observed caused by deletion of Ncoa7 by exogenous replace-
ment of the protein. We show an interaction of NCOA7 
with several subunits critical for the correct formation of 
the V-ATPase V1 complex domain, including ATP6V1B2 
and ATP6V1C [54]. Indeed, variants in human ATP6V1B2 
that are predicted to alter interactions within the V1 complex 
cause dominantly-inherited neurodevelopmental disorders 
[55, 56]. Although we observed a significant shift in dis-
tribution of the ATP6V1B2 and ATP6V1A1 subunits away 
from the membrane in DEL neurons, no changes in the abso-
lute levels of ATP6V1B2 were detected in the brain or pri-
mary cells. These data are consistent with a number of other 
crucial V-ATPase modulators—such as the accessory pro-
tein ATP6AP2—that does not affect subunit expression, but 
does disturb the ratio of membrane-assembled ATP6V1B2 
to V0 subunits [55, 56]. Of note, de novo ATP6AP2 deletion 
variants have also been described in neurological disease, 
Fig. 6  Ncoa7 deletion alters neuronal development and decreases 
inhibitory synapse density in primary neruons. a Representative con-
focal microscopy images of WT and DEL primary cortical neurons 
(5-DIV) and the relative RESCUE experiment (DEL neurons express-
ing exogenous NCOA7) labelled with β3-tubulin. Scale bar: 20 μm. b 
Sholl analysis of cortical neuron arborisation as a function of distance 
from the soma. c Quantification of neurite length and d number from 
the Sholl analysis. e Representative high-magnification of proximal 
dendrites from cortical neurons. The black-and-white panels show the 
positive colocalisation between VGAT and Gephyrin along branches 
of WT, DEL and RESCUE neurons. Scale bar: 5 μm. f Quantitative 
analysis of synaptic punta counted on 30 μm branches starting from 
the cell body. g Representative images of proximal dendrites from 
primary cortical neurons. The black-and-white panels show the posi-
tive colocalisation between VGLUT1 and Homer1 along branches of 
WT and DEL neurons. Scale bar: 5  μm. h Quantitative analysis of 
VGLUT/Homer1-positive puncta counted on 30 μm branches starting 
from the cell body. Data are expressed as the mean ± SEM from n = 3 
independent primary cell preparations. *p < 0.05; two-way ANOVA/
Bonferroni’s multiple comparison test (b), one-way ANOVA/Bonfer-
roni’s multiple comparison test (c, d) and unpaired Student’s t test 
(f–h)
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altering neuronal development, LC3b abundance and lyso-
somal function when modelled in the mouse and human 
stem cell-derived neurons [56, 57]. Furthermore, absence 
of VPS50, another V-ATPase accessory protein, not only 
alters dense-core vesicle acidification, but is also implicated 
in neural tube formation in humans [58]. Thus, our data 
provides further evidence for the importance of V-ATPase 
regulation for neurodevelopment. Moreover, our detection 
of cytosolic accumulation of potentially undegraded mate-
rial in DEL neurons is consistent with similar examples of 
V-ATPase subunit disruption [59, 60], supporting our find-
ings that the absence of NCOA7 negatively affects lysoso-
mal physiology. We did not, however, observe evidence for 
more overt lysosomal storage in primary neurons as has been 
described in other V-ATPase-associated mutant models [56].
We further demonstrate that loss of Ncoa7 causes 
altered dendritic outgrowth, a reduction in the number of 
CB interneurons and the numbers of inhibitory synapses; 
in addition, homozygous mutants exhibited anxiolytic 
behaviour in two behavioural assays and altered sociabil-
ity in the three-chamber test. Multiple brain structures are 
involved in the regulation of anxiety and social behaviours, 
such as the amygdala, thalamus, hippocampus and cortical 
areas [61–65]. Our developmental expression data show 
that Ncoa7 is found in all of these key neuroanatomical 
regions, in addition to those related to olfaction, a fun-
damental feature of mouse exploratory activity, anxiety 
and sociability [62]. Furthermore, direct alterations of 
excitatory and inhibitory balance within the brain have a 
strong effect on social motivation, potentially underlying 
the deficits seen in social novelty and interaction [66]. 
Deficient GABAergic transmission has been described 
in anxiety [67, 68], and enhancement of GABAergic 
transmission through pharmacological action has been 
shown to reduce anxiety behaviours [69, 70]. Conversely, 
GAD67, the enzyme responsible for GABA production, 
has been linked to anxiety disorders [71]. We postulate 
that the behavioural effects of Ncoa7 deletion we see may 
result from the reduced CB-positive interneurons in the 
cortex and the subsequently reduced number of inhibi-
tory synapses observed in the cerebral cortex. This overall 
reduction of the inhibitory circuitry observed in Ncoa7 
mutant mice may affect the connectivity between cortical 
and ventral brain areas involved in the regulation of anxi-
ety and sociability, behavioural outcomes relevant to the 
recent association of the gene to autism [27].
Fig. 7  Ncoa7 deletion affects 
inhibitory synapse density and 
alters the number of calbindin-
positive interneurons in vivo. 
a Representative confocal 
images of the layer 2/3 in 
the somatosensory cortex of 
WT and DEL brain sections 
immunostained with VGLUT1, 
VGAT and their merged signals. 
Quantification of the number 
of VGLUT1 (b) and VGAT 
(c) immunoreactive puncta. d 
Representative calbindin immu-
nostaining of the somatosensory 
and visual cortex from WT and 
DEL brain sections and e, f 
quantification. Data represents 
anatomically matched brain 
slices from n = 4 WT and DEL 
mice. Data are expressed as 
the mean ± SEM. *p < 0.05; 
unpaired Student’s t test
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Our cellular localisation studies point towards a mem-
brane-associated role for NCOA7, including interactions 
with a number of specific PIPs that are not only implicated 
in vesicle trafficking and endolysosomal homeostasis, but 
also the recruitment of the V-ATPase to the membrane 
[37–39, 72]; indeed, the range of PIP interactions suggest 
multiple potential intracellular sites of action. Interest-
ingly, structural studies have demonstrated that the TLDc 
Fig. 8  Ncoa7 deletion induces anxiety-like behaviour and social 
impairment. a Light–dark box behavioural data plotted as total time 
in the light (green) or dark (blue) zones per WT or DEL animal dur-
ing the trial and b the cumulative number of transitions between the 
light and dark (green) or dark and light (blue) zones. c Elevated zero-
maze behavioural data plotted as total time in the light (green) or dark 
(blue) zones per WT or DEL animal during the trial and d frequency 
of entries into each zone. e–h Social preference testing during and 
initial habitation phase (green) and novelty phase (orange), where a 
new mouse in a cage is added to the apparatus (e) verses an empty 
cage (g). Data are plotted as zone duration (e, g) in addition to cumu-
lative zone entrance frequency during both phases (f, h). *p < 0.05, 
**p < 0.01, ***p < 0.001, ns not significant. Two-way ANOVA/
Bonferroni’s multiple comparison test. Data are expressed as the 
mean ± SEM. Data points represent individual animals
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protein TBC1D24 contains a PIP-binding pocket situated 
in the N-terminal TBC domain [73], thus it is notewor-
thy that the same repertoire of PIPs interact with both 
TBC1D24 and NCOA7 [73]. Furthermore, it is particu-
larly intriguing that in a recently described microdeletion 
syndrome, certain clinical features including seizures have 
been narrowed-down genetically to haploinsufficiency of 
TBC1D24 and the neighbouring V-ATPase V0 subunit 
gene ATP6V0C [74, 75]. Together with the description 
of OXR1 as a potential ATP6V1B1 interactor in kidney 
tissue [32] and lysosomal abnormalities reported in cells 
derived from loss-of-function OXR1 patients [17], it is 
apparent that the TLDc domain may be a critical func-
tional regulator of V-ATPase function, with alternative 
domains (e.g., TBC or GRAM) assisting with anchoring 
to the membrane.
Fig. 9  Expression of TLDc 
proteins in DEL mice and co-
expression of Oxr1 and Ncoa7 
in the brain. a Representative 
Western blots of TBC1D24 and 
OXR1 from the age-matched 
WT and DEL whole cerebral 
cortex tissue quantified with 
β3-tubulin as the loading con-
trol. b Dual-fluorescence in situ 
hybridisation of Ncoa7 (green) 
and Oxr1 (red) with the merged 
signal in the brain regions and 
timepoints indicated. Scale 
bars: 100 μm for cerebellum 
and 200 μm for the remaining 
panels. Data are expressed as 
the mean ± SEM. n = 5 for WT 
and DEL in (a)
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One reason to generate this unique Ncoa7 deletion model 
was in part due to the presence of the short TLDc domain-
containing isoform of NCOA7 (NCOA7-B), considering that 
we and others have shown that a similar short OXR1 isoform 
can compensate for disruption of the corresponding full-
length version [29, 30, 53]. In a very recent example, disrup-
tion of a single, full-length, brain-specific OXR1 isoform in 
the mouse resulted in growth hormone release abnormalities 
[76], but no neurodegeneration as we observe in our Oxr1d/d 
knockout [30]. Therefore, we might have expected a more 
severe phenotype in the homozygous DEL mutant described 
here that lacks all possible Ncoa7 isoforms. Specific activa-
tion of the short NCOA7-B isoform occurs via an interferon 
(IFN)-mediated pathway and has been shown to be protec-
tive against viral infection in vitro [29, 77]. It is, therefore, 
possible that the brain does not require this particular short 
isoform to be active under basal conditions, and the presence 
of OXR1 in Ncoa7 DEL animals is sufficient to avoid the 
severe neurodegenerative phenotypes caused by complete 
OXR1 loss-of-function as observed in humans and mice [17, 
30].
Our data suggest that aspects of endolysosomal dysfunc-
tion caused by loss of all Ncoa7 isoforms in the nervous 
system may underlie the behavioural changes we observe, 
although additional roles of the gene—including those yet 
to be determined—may also be involved. NCOA7 is clas-
sified as an ER-mediated transcriptional regulator, even if 
experimental evidence for this function is still limited. Yet 
it is noteworthy that other steroid receptor coactivators such 
as NCOA1/SRC1 are known to be important, rate-limiting 
modulators of transcriptional cascades implicated in neu-
rodevelopment and behaviour, including aspects of cogni-
tion in Alzheimer’s disease [78]. Furthermore, with specific 
relevance to the recent discovery of NCOA7 mutations in 
autism, several de novo genetic variants in the nuclear recep-
tor corepressors NCOR1 and NCOR2 are found in pediatric 
patients with intellectual disabilities or ASD [78]. As such, 
despite our fractionation experiments in brain tissue fail-
ing to detect NCOA7 in the nucleus, the deregulation of 
neurodevelopmentally-critical transcriptional pathways due 
to a deletion of Ncoa7 cannot be ruled-out.
In the kidneys of DEL mice a significant reduction in 
ATP6V1B1 expression was observed, similar to studies 
of an Ncoa7 full-length isoform mutant (Ncoa7-tm1.1) 
[33]. We were also able to show in vivo binding between 
NCOA7 and ATP6V1B1, yet the cause of this reduced 
expression—not observed for V1 subunits in the brain 
from our DEL mutant—is unclear. It is possible that desta-
bilised V-ATPase subunits are targeted for degradation; 
indeed, a chaperone-like role for NCOA7 binding to the 
B1 subunit is plausible, given the similar role for OXR1 
in stabilising catalytic multimers [79, 80]. Alternatively, 
a tissue-specific transcriptional feedback loop involving 
the regulatory activity of NCOA7 on V-ATPase subunit 
expression could be involved. Importantly, our urine pH 
data are consistent with V-ATPase dysfunction in the 
intercalated cells of the kidney as well as an incomplete 
renal acidosis (dRTA) phenotype as described in Ncoa7-
tm1.1 homozygous mutants and Atp6v1b1 knockout mice 
[33, 81]. The increase in urine pH of approximately 1 unit 
in DEL mice is comparable to that in the homozygous 
Ncoa7-tm1.1 line  [33], suggesting that the additional 
removal of the short NCOA7-B isoform in DEL mutants 
does not exacerbate V-ATPase dysfunction in the kidney. 
Undoubtedly, further functional studies of both NCOA7 
isoforms outside of the nervous system are warranted in 
the future.
Our in situ hybridisation studies of Ncoa7 and Oxr1 pre-
sented here show obvious regions of co-expression across 
the brain, although there was no evidence for the induction 
of OXR1 or TBC1D24 at the protein level in Ncoa7 DEL 
tissue. It is particularly interesting in the mouse cerebel-
lum that Oxr1 is expressed predominantly in the granule 
cell layer of neonates and adults, whereas Ncoa7 is clearly 
enriched in Purkinje cells at both timepoints. These data 
suggest that the specific pattern of cell death apparent in the 
granule cell layer of Oxr1d/d animals may be due to a rela-
tive lack of Ncoa7 that is unable to compensate functionally 
compared to other brain regions at that timepoint. To begin, 
therefore, to assess a genetic interaction between TLDc pro-
teins for the first time in the mouse in vivo, we crossed our 
DEL mutant with an Oxr1 loss-of-function model such that 
the TLDc domain of all potential isoforms of both genes 
could be disrupted. Although mice haploinsufficent for Oxr1 
on an Ncoa7 knockout background and those heterozygous 
for Ncoa7 in the Oxr1 knockout model are viable, no dou-
ble-null mutants were obtained even at early embryonic 
timepoints. This underlies the importance of TLDc genes 
during development and demonstrates that not all proteins 
that contain this conserved domain can fully compensate for 
one another in a mammalian system; future work will assess 
in more detail the genetic interaction between TLDc fam-
ily members. Indeed, loss-of-function mutations of ubiqui-
tously-expressed V-ATPase subunits are non-viable in mice, 
where there is no functional redundancy in the system [82].
In summary, mice lacking the entire Ncoa7 locus lead to 
altered V-ATPase formation in neurons alongside lysosomal 
defects that influence neuronal development, synaptic forma-
tion and ultimately behaviour. It has become clear that the 
V-ATPase has profound effects on many pH-dependent cel-
lular processes [83]; consequently, regulation of V-ATPase 
assembly and function has been proposed as a viable thera-
peutic target in a wide range of human disorders [84–86]. In 
the future, it will be important to determine whether TLDc 
proteins can be harnessed as a novel V-ATPase gating mech-
anism applicable to many physiological states, where there 
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is a fundamental necessity to control vesicular acidification, 
not limited to the obvious importance of this process for 
neuronal development and connectivity.
Materials and methods
Experimental animals and housing
Animals were generated and maintained under UK Home 
Office Project Licences 30/2966, 30/3353 and P7133CD66 
with local ethical guidelines issued by the University of 
Oxford and the Medical Research Council Harwell Insti-
tute. Animals had ad libitum access to food and water and 
were kept under a controlled 12 h light/dark cycle, tempera-
ture (21 ± 2 °C) and humidity (55 ± 10%). All experimental 
animals were maintained on a C57BL6/J background and 
backcrossed over 10 generations before intercrossing, elimi-
nating the risk of any residual off-target mutagenesis con-
tributing to the phenotype. The Ncoa7 deletion (DEL) line 
was created by CRISPR/Cas9-mediated deletion of entire 
Ncoa7 coding region. Guide-RNAs were designed using 
the CRISPOR algorithm (http://crisp or.tefor .net) against 
genomic sequences lying immediately upstream and down-
stream of the Ncoa7 start and stop codons and selected on 
the basis of genome specificity, with at least 3 mismatches 
in distal positions relative to the PAM needed to achieve an 
off-target match against the mouse genome. Guide-RNAs 
were designed and validated as described previously [19], 
but here for activity against genomic sequences lying imme-
diately upstream and downstream of the Ncoa7 start and stop 
codons (#740: 5′-GCG CCC GGC GCC CTG ACC GT-3′ and 
#736: 5′-ACA TGA GTT GGC GAG ATC CC-3′). The guides 
were generated by in vitro transcription and microinjected 
at a concentration of 5 ng/μl, together with Cas9 mRNA at 
10 ng/μl, into a pronucleus of fertilized C57BL/6J oocytes. 
In the resulting litters, a founder mouse was identified with 
a confirmed deletion spanning 157,481 bp that was success-
fully transmitted to the next generation. Breakpoints were 
confirmed by Sanger sequencing. Mice were screened ini-
tially using primers for presence of the deletion: Ncoa7-F1 
5′-AGG CAA TGC TGG AAA TGA CAG AGG -3′ (wild-type 
penultimate coding exon), Ncoa7-R1 5′-CCC TGG AAT GGA 
TCA TGT CAT GTC -3′ (wild-type 3′ UTR sequence and 3′ 
end of deletion) and Ncoa7-F2 5′-GAT TGC CTC CCT CTT 
ATG AAA GCC -3′ (wild-type 5′UTR sequence and 5′ end 
of the deletion). Oxr1 knockout animals were genotyped as 
described previously [53].
Behavioural phenotyping tests
For all behavioural phenotyping tests, mice were taken to 
the test room at least 20 min before the start of the test to 
acclimatise and apparatus was cleaned between individuals 
to avoid olfactory cues. Investigators were blind to genotype 
during all phenotyping tests. A battery of tests was carried 
out on cohort of age-matched female WT (N = 8) and DEL 
(N = 9) starting at 3 months of age in the order described 
below. For video tracking, all experiments were analysed 
using Ethovision XT software (Noldus, The Netherlands).
Open field activity
Animals were placed individually in square opaque Plexiglas 
arenas (44 × 44 cm) with lighting set at 150–200 lux and 
were video-tracked for 20 min.
Elevated zero‑maze
Mice were placed in an open arm of an elevated ring-
shaped runway with the same area devoted to adjacent open 
(30 cm × 5 cm) and closed quadrants (30 cm × 5 cm × 15 cm) 
and video-tracked for 5 min, during which their preference 
for the open or closed quadrant was scored.
Dark–light box
Mice were placed in the open area of the box consist-
ing of an open (40  cm × 40  cm × 20  cm) and closed 
(40 cm × 20 cm × 40 cm) area and video-tracked for 10 min, 
during which their preference for the open or closed area 
was scored.
Y‑maze
To evaluate short-term working memory mice were placed 
in the ‘start’ arm of a Y-shaped transparent maze (three iden-
tical arms 35 cm × 5 cm × 15 cm) with access to one arm 
blocked, they were then free to explore the ‘start’ arm and the 
‘familiar’ arm for 10 min. Mice were returned to the home 
cage for a two-minute inter-trial interval, and then returned 
to the maze, with access to all three arms for 5 min with time 
spent in the ‘novel’ versus ‘familiar’ arm recorded.
Rotarod
To assess coordination and motor learning, mice were placed 
on an accelerating rotarod (Ugo Basile), with rotor speed 
increasing from 4 rpm up to 40 rpm over 5 min. The time 
taken for the mouse to fall from the rod was recorded. One 
trial per day was carried out over three consecutive days.
Contextual and cue fear conditioning
Conditioning phase: a mouse was placed in the test chamber 
[Fear Conditioning System (Ugo Basile, Italy)] and allowed 
The Ncoa7 locus regulates V-ATPase formation and function, neurodevelopment and behaviour 
1 3
to explore freely for 2 min. A pure tone (5 kHz, 80 dB) serv-
ing as the conditioning stimulus (CS) was played for 20 s. 
During the last 1 second of the tone, a foot shock (0.5 mA) 
was delivered as the unconditioned stimulus (US). The 
mouse was left in the chamber for another 2 min. Context 
phase: 24 h after conditioning, mice were placed in the same 
chamber and freezing behaviour recorded for 5 min in the 
absence of any stimuli. Mice were then returned to their 
home-cage. Cue phase: 4 h after the context phase, mice are 
placed in a round Plexiglas cylinder with vanilla fragrance 
spread at the top of the cylinder for 6 min during which the 
mouse is exposed to the same sound as in the conditioning 
phase. Both freezing behaviour and activity was scored.
Three chamber social test
M i c e  we r e  p l a c e d  i n  a  m i d d l e  ch a m b e r 
(23 cm × 40 cm × 22 cm) of a transparent arena with access 
to both of the other two chambers (23 cm × 40 cm × 22 cm) 
via an opening. They were then free to explore the arena 
for ten minutes. Mice were returned to the home cage for 
a two-minute inter-trial interval, during which the arena 
was cleaned to remove odour cues, and an object (single-
mouse cage) and a novel mouse (in a single-mouse cage) 
were placed in either the left or right chamber, during which 
their preference for the object or the novel mouse was scored 
by the time spent and the frequency of visits in the novel 
object’s or novel mouse’s chamber. The place of the object 
and the novel mouse were alternated during each trial.
Social dominance test
One age-matched WT and DEL mouse of a similar wight 
were allowed to enter at opposite ends of a transparent poly-
vinyl chloride tube (30 cm × 4 cm). After the mice meet at 
the centre of the tube, the first mouse to reverse out of the 
tube is considered subordinate. Each mouse performed 5 
challenges against a different mouse and the percentage of 
challenges won was recorded.
Primary neuronal cultures and transfection
Low-density primary cortical neurons were prepared from 
P0 brains as previously described [86]. Briefly, cerebral cor-
tices were dissociated by enzymatic digestion and dissoci-
ated neurons were plated at low density (200 cells/mm2) 
onto poly-d-lysine-coated 25 mm glass coverslips. For evalu-
ation of rescue experiments, DEL neurons were nucleofected 
before plating with the 4D-Nucleofector System (Lonza) 
with the high viability protocol for primary mouse neurons 
and then analysed for GFP expression. Mouse full-length 
NCOA7 constructs were either C-terminal HA-tagged 
in vector pcDNA3.1 or C-terminal GFP-tagged in vector 
pEGFP.
Real‑time PCR
Total RNA was isolated from different brain areas as previ-
ously described [86] and 500 ng used for cDNA synthesis 
with RevertAid reverse transcriptase (Thermofisher Sci-
entific). Real-time PCR analyses were performed using 
SYBR Green I Mastermix (Roche) on a 7500 Fast Real-
Time System (Applied Biosystem) with the following pro-
tocol: 95 °C for 10 min; 30 s at 95 °C/20 s at the specific 
annealing temperature (Ta)/30 s at 72 °C for 45 cycles; 
melting curve (heating ramp from 55 to 95 °C) to check for 
amplification specificity. Each individual well used 1/100 
of the original cDNA reaction. The Ncoa7 exon 3-specific 
primers FW 5′-CAG CTG CGT CCT CGA AGA G-3′ and Rev 
5′-GCT GTA ACG TTG AAC TTG TCT TGT TC-3′ were used 
to detect Ncoa7 full-length transcripts and S16 FW 5′-TTC 
TGG GCA AGG AGC GAT T-3′ and Rev 5′-GAT GGA CTG 
TCG GAT GGC A-3′ was used as internal control.
Subcellular fractionation, immunoprecipitation 
and western blotting
Low density cortical primary neurons were plated as 
described above. Neurons were placed on ice and washed 
twice with ice-cold PBS. Neurons were scraped into homog-
enization buffer (250 mM sucrose, 1 mM EDTA, 10 mM 
PMSF, 2 μg/ml aprotinin, 5 μg/ml leupeptin, and 1 μg/ml 
pepstatin) and lysed by repeated passage through a ball bear-
ing homogenizer. The homogenate was cleared of intact 
cells and nuclei by centrifugation at 500×g  for 10 min. 
The supernatant was subjected to ultracentrifugation at 
100,000×g for 30 min to pellet the membrane fraction. The 
supernatant containing the cytosolic fraction was concen-
trated using Amicon Ultra 10 K centrifugal filters according 
to the instructions of the manufacturer. Resulting cytosolic 
samples were supplemented with 1% SDS to yield the final 
cytosolic fractions. Membrane pellets were rinsed once with 
homogenization buffer and resuspended in homogenization 
buffer containing 1% SDS to yield the final membrane frac-
tions. NCOA7, ATP6V1B2, ATP6V1A, and ATP6V1C were 
immunoprecipitated from cell lysates using the Pierce Cross-
link Immunoprecipitation Kit (Thermo Fisher Scientific) as 
specified by the manufacturer. Antibodies were coupled 
to the Pierce Protein A/G Plus Agarose for 1 h, and then 
crosslinked to the resin using the DSS crosslinker (2.5 mM 
in DMSO) for 1 h. Subsequently, 500–1000 µg of lysates 
were incubated on the column overnight at 4 °C. The eluates 
were finally loaded on NuPAGE Bis–Tris 4–12% polyacryla-
mide precast gel and analysed for presence of the antigen. 
Western blotting experiments and analysis were performed 
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as previously described [87]. Primary neurons and brain tis-
sue were lysed in RIPA buffer using Lysing Matrix tubes for 
homogenisation (MP Biomedical). The following antibod-
ies were used: anti-NCOA7 (1:1000, ProteinTech 23092-1-
AP), anti-ATP6V1B2 (1:2000, ProteinTech 15097-1-AP), 
anti-ATP6V1A(1) (1:2000, ProteinTech  17115-1-AP), 
anti-ATP6V1D(1) (1:1000, ProteinTech  14920-1-AP), 
anti-ATP6V0a1 (1:1000, ProteinTech 13828-1-AP), anti-
ATP6V0d1 (1:1000, ProteinTech 18274-1-AP), anti-AT1A1 
(1:1000, Millipore 05-369), anti-viniculin (1:500, Cell Sign-
aling 4650), anti-ATP6V1B1 (1:1000, ProteinTech 14780-1-
AP), anti-tubulin (1:5000, Biolegend 657401), anti-Cathep-
sin D (1:2000, Abcam ab6313), anti-Cathepsin B (1:1000, 
Merck ab125067), anti-LAMP1 (1:1000 Abcam ab24170), 
anti-Rab7 (1:1000, Abcam  ab137029), anti-Cofilin 
(1:1000, Abcam ab42824), anti-TBC1D24 (1:1000, Pro-
teintech 25254-1-AP) and anti-OXR1 (1:1000, Protein-
tech 13514-1-AP). Proteins was visualized using anti-mouse 
(P/N 926–68,070) or anti-rabbit (P/N 926–32,211) second-
ary antibodies IRDye (LiCor Biosciences) at 1:10,000 dilu-
tions and quantified using the scanning infrared Odyssey 
imaging system CX (LiCor Biosciences).
PIP interaction assay
Full-length NCOA7 recombinant protein (OriGene) was 
incubated with PIPs strip Membrane (ThermoFisher) con-
taining 100 pmol of lipid per spot overnight. The membrane 
was then incubated with an anti-NCOA7 (1:1000, Protein-
Tech). The protein–lipid interaction was visualized using an 
anti-rabbit secondary antibody IRDye (LiCor Biosciences) 
at 1:10,000 dilution and quantified using the scanning infra-
red Odyssey imaging system CX (LiCor Biosciences).
Immunofluorescence and immunohistochemistry
Immunofluorescence experiments and analysis were per-
formed as previously described [84]. For Ncoa7 mutant 
tissue analysis, animals were transcardially perfused with 
4% PFA, sections cut at 30 μm using a vibratome (Leica) 
and processed for free-floating immunofluorescence. The 
following primary antibodies were used: mouse ant-NeuN 
(1:500, Millipore MAB377), rabbit anti-VGAT (1:300, Syn-
aptic Systems 131003), mouse anti-VGLUT1 (1:250, Syn-
aptic Systems 135 311) and anti-Calbindin (1:5000, Novus 
Biological). Images were acquired with a Zeiss LSM 700 
confocal microscope (Carl Zeiss AG) using the multitrack 
mode to avoid fluorescence crosstalk (pinhole: 1.0 airy unit). 
For cell death quantification in Oxr1 mutants, 14 μm par-
asagittal sections from perfused brains taken at P22 were 
immunostained for cleaved caspase-3 Asp175 (1:500, Cell 
Signaling) and the Vectorstain Elite ABC kit (Vectorlabs). 
A total of 8 anatomically matched sections at equidistant 
intervals from 4 mice of each genotype were visualized by 
light microscopy. For the quantitative analysis of VGAT and 
VGLUT1 puncta, fluorescence levels were analysed on con-
focal images by measuring pixel intensity using ImageJ. His-
tology was performed on neurons labelled with anti-NeuN. 
Frontal, medial and caudal sections were chosen to calculate 
cortical regions, corpus callous and hippocampal regions 
thicknesses. Images from the cerebellum were always 
acquired from the fourth/fifth lobe to measure the thickness 
of granule cell and molecular layers. Images were acquired 
at 20× and all parameters were analysed using Fiji software. 
Immunofluorescence on primary neurons was performed as 
previously described [88]. Briefly, neurons were fixed in 4% 
paraformaldehyde and then immunostained. Fluorescence 
intensity and density of positive-puncta measurements were 
performed using ImageJ. Fluorescence intensity of endog-
enous LAMP1 staining was measured as mean intensity and 
expressed in arbitrary units of fluorescence per cell area. 
LAMP1 positive puncta were measured in each z-stack and 
normalised on the cell area. Antibodies were used as fol-
lows: anti-LAMP1 (1:500; Developmental Studies Hybri-
doma Bank 1D4B), anti-β3-tubulin (1:1000; Biolegend), 
anti-GFP (1:1000; Thermo Fisher Scientific A-11122). As 
a control for the staining and the acquisition procedure, the 
primary antibodies were omitted. The analysis of synapse 
density was performed as previously described [43]. Sholl 
analysis was performed as previously described [18], and the 
number of intersections was automatically evaluated with 
the ImageJ/Sholl analysis plug-in.
Live imaging
For LysoTracker Green DND-26 (Thermo Fisher Scien-
tific L7526 ) experiments, primary cortical neurons (7-DIV) 
were incubated with LysoTracker solution (LysoTracker 
100 nM in Neurobasal-A (Thermo Fisher Scientific) com-
plemented with 1% Penicillin–Streptomycin, 1% GlutaMax, 
2% B-27 (Thermo Fisher Scientific) for 10 min at 37 °C and 
5% of  CO2. At least 20 neurons each from 3 different prepa-
ration were imaged. After incubation, neurons were washed 
with FluoroBrite imaging media (Thermo Fisher Scientific) 
and immediately acquired with a Zeiss LSM 700 confocal 
microscope (Carl Zeiss AG) equipped with a 37 °C and 5% 
 CO2 chamber. For the quantitative analysis of LysoTracker-
positive organelles, Z-series stacks of 4 consecutive confo-
cal Sections (1024 × 1024) were acquired at 40× magnifica-
tion. Images were acquired in less than 20 min to prevent 
LysoTracker dispersion. Lysotracker positive puncta were 
measured in each z-stack and normalised on the cell area. To 
determine the degradation of ectopically transduced dextran, 
primary cortical neurons (7–10 DIV) were incubated with 
100 μg/ml Alexa Fluor 594 labelled dextran (Thermo Fisher 
Scientific D22913) for 6 h. After washing with Tyrode 
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solution (140 mM NaCl, 3 mM KCl, 2 mM  CaCl2, 1 mM 
 MgCl2, 10 mM glucose, 10 mM HEPES-buffered to pH 7.4), 
neurons were immediately imaged with a Zeiss LSM 700 
confocal microscope (Carl Zeiss AG) equipped with a 37 °C 
and 5%  CO2 chamber, or incubated with fresh Neurobasal-A 
complemented as described above for 1 h and then acquired. 
To live label protease-mediated hydrolysis of BSA, pri-
mary cortical neurons (7-DIV) were incubated with 50 μg/
ml DQTM Red-BSA (Thermo Fisher Scientific D12051) 
at 37 °C for 2 h. Neurons were then washed with Tyrode 
solution and immediately live imaged as described above, 
or incubated with fresh Neurobasal-A complemented as 
described for 1 h and then acquired. All the parameters were 
analysed using Fiji software. Fluorescence intensity of the 
different dyes was measured as mean intensity and expressed 
in arbitrary units of fluorescence on the cell area.
FITC‑dextran pH calculation
To determine the pH of endocytic compartments, primary 
cortical neurons were incubated with 100 μg/ml of fluores-
cein isothiocyanate (FITC) labelled dextran (Merck Milli-
pore 46944) for 2 h. After washing with Neurobasal medium, 
supplemented as described above, cells were incubated with 
fresh medium for 30 min. Neurons were live imaged at the 
confocal microscope as described above. A pH calibration 
curve was then collected for each coverslip using 10 μM 
Valinomycin and 10 μM Nigerin in HEPES buffer (pH 7.5) 
and MES buffer (125 mM KCl, 25 mM NaCl, 25 mM MES, 
pH 6.5, 5.5 and 4.5). FITC-Dextran intensity in both chan-
nels was calculated after background subtraction and ratio 
(495/450) were fitted to a linear regression with the Graph-
Pad Prism 5 software. Data were best fitted in the range of 
pH 4.5–7.5. For pH evaluation, measured ratios were con-
verted into absolute pH values by interpolation in the cali-
bration function (y = 31.751x–138.76, R2 = 0.9873).
In situ hybridization
For riboprobe synthesis, regions representing all iso-
forms of Oxr1 (3085–3486 bp of NCBI accession num-
ber NM_001130166.1) and Ncoa7 (3261–3572  bp of 
NM172495.6) were used. DIG-labelled non-fluorescent 
probe hybridisation and detection on fresh frozen Sections 
(14 μm) for Ncoa7 was carried out as previously described 
[89]. For dual-fluorescent reactions, the Oxr1 riboprobe 
was DNP-labelled and Ncoa7 was DIG-labelled. Probe 
hybridization and detection was carried out using the TSA 
Plus Fluorescence Systems with Cy3 and Fluorescein as 
per the manufacturer’s instructions (Perkin Elmer), using 
sheep-anti-DIG-POD Fab fragments (1:500; Roche) or 
anti-DNP-POD (1:100; Perkin-Elmer) and a final 1:100 dilu-
tion of the tyramide detection reagent for 15 min. Peroxidase 
activity of the previous antibody was inactivated by washing 
the slides with PBS containing 0.1% Tween-20 and 6%  H2O2 
for 10 min prior to labelling with the second riboprobe.
Electron microscopy
For transmission electron microscopy, low density primary 
cortical neurons were fixed at 14–18 DIV with 1.2% gluta-
raldehyde in 66 mM sodium cacodylate buffer, post-fixed 
in 1%  OsO4, 1.5%  K4Fe(CN)6, 0.1 M sodium cacodylate, 
en bloc stained with 1% uranyl acetate, dehydrated, and flat 
embedded in epoxy resin (TAAB Epon 812). After baking 
for 48 h, the glass coverslip was removed from the Epon 
block by thermal shock and neurons were identified by 
means of a stereomicroscope. Embedded neurons were then 
excised from the block, and mounted on a cured Epon block 
for sectioning using an EM UC6 ultramicrotome (Leica 
Microsystems). Ultrathin Sections (60–70 nm thick) were 
collected on 200-mesh copper grids (EMS) and observed 
with a FEI Tecnai T12 transmission electron microscope 
operating at 100 kV using an ORIUS SC1000 CCD camera 
(Gatan). For each experimental condition, at least 30 images 
were acquired at 10,000× magnification (sampled area per 
experimental condition: 20 µm2). Neuronal morphometry 
were determined using ImageJ software.
Urine analysis
Mouse urine was collected directly onto Hydrion Urine 
& Saliva pH Paper 5.5–8.0 (Micro Essential Laboratory) 
between 07.30 and 08.30 am and pH was read by two differ-
ent, blinded investigators.
Statistical analysis
Data are expressed as the mean ± SEM throughout. To com-
pare two normally distributed sample groups, the two-tailed 
Student’s t-test was used. In case of more than two normally 
distributed experimental groups, one- or two-way ANOVA 
followed by multiple comparison tests were employed 
as stated. Significance level was preset to p < 0.05. Data 
were analysed using Prism 6.0 (GraphPad Software, Inc.) 
software.
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